TY - JOUR
T1 - Chronic obstructive pulmonary disease and anxiety disorders
T2 - A nationwide population-based study in Taiwan
AU - Hsieh, Ming Han
AU - Lee, Charles Tzu Chi
AU - Tsai, Pei Jung
AU - Tsai, Chia Jui
AU - Liao, Yin To
AU - Chen, Vincent Chin Hung
AU - Stewart, Robert
N1 - Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2016/9/1
Y1 - 2016/9/1
N2 - Objective: Few studies have investigated the relationship between chronic obstructive pulmonary disease (COPD) and anxiety disorder outcomes. We sought to investigate the association in a large national sample. Methods: Cases were identified from Taiwan's National Health Insurance Research Database who were aged 15 years and above, with a new primary diagnosis of COPD (International Classification of Diseases, Ninth Revision codes: 491, 492, 494 and 496) between 2000 and 2007. The 29,951 cases identified were compared to 29,951 controls matched on sex, age, urban/rural residence and socioeconomic status based on insurance premium. Both groups were followed until the end of 2008 for instances of anxiety disorders. Competing risk-adjusted Cox regression analyses were applied, adjusting for matching variables, Charlson comorbidity index, hospital admission days and daily dose of prednisone. Results: Of the 59,902 subjects, 3951 were found to have anxiety disorders during a mean (SD) follow-up period of 5.5 (2.5) years. COPD, female, urban residence, lower dose of prednisone use, depressive disorders and higher outpatient visits were independent predictors of incident anxiety disorder. Conclusions: COPD was associated with increased risk of an anxiety disorder diagnosis, independent of a number of potential confounding factors.
AB - Objective: Few studies have investigated the relationship between chronic obstructive pulmonary disease (COPD) and anxiety disorder outcomes. We sought to investigate the association in a large national sample. Methods: Cases were identified from Taiwan's National Health Insurance Research Database who were aged 15 years and above, with a new primary diagnosis of COPD (International Classification of Diseases, Ninth Revision codes: 491, 492, 494 and 496) between 2000 and 2007. The 29,951 cases identified were compared to 29,951 controls matched on sex, age, urban/rural residence and socioeconomic status based on insurance premium. Both groups were followed until the end of 2008 for instances of anxiety disorders. Competing risk-adjusted Cox regression analyses were applied, adjusting for matching variables, Charlson comorbidity index, hospital admission days and daily dose of prednisone. Results: Of the 59,902 subjects, 3951 were found to have anxiety disorders during a mean (SD) follow-up period of 5.5 (2.5) years. COPD, female, urban residence, lower dose of prednisone use, depressive disorders and higher outpatient visits were independent predictors of incident anxiety disorder. Conclusions: COPD was associated with increased risk of an anxiety disorder diagnosis, independent of a number of potential confounding factors.
KW - Anxiety
KW - Charlson comorbidity index
KW - Chronic obstructive pulmonary disease
KW - Prednisone
UR - http://www.scopus.com/inward/record.url?scp=84974621411&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84974621411&partnerID=8YFLogxK
U2 - 10.1016/j.genhosppsych.2016.05.005
DO - 10.1016/j.genhosppsych.2016.05.005
M3 - Article
C2 - 27638963
AN - SCOPUS:84974621411
SN - 0163-8343
VL - 42
SP - 1
EP - 6
JO - General Hospital Psychiatry
JF - General Hospital Psychiatry
ER -